These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 32212957)

  • 21. Analysis by metadynamics simulation of binding pathway of influenza virus M2 channel blockers.
    Sakai Y; Kawaguchi A; Nagata K; Hirokawa T
    Microbiol Immunol; 2018 Jan; 62(1):34-43. PubMed ID: 29210473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of the pore-lining residues of the BM2 ion channel protein of influenza B virus.
    Ma C; Soto CS; Ohigashi Y; Taylor A; Bournas V; Glawe B; Udo MK; Degrado WF; Lamb RA; Pinto LH
    J Biol Chem; 2008 Jun; 283(23):15921-31. PubMed ID: 18408016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of Action of Novel Influenza A/M2 Viroporin Inhibitors Derived from Hexamethylene Amiloride.
    Jalily PH; Eldstrom J; Miller SC; Kwan DC; Tai SS; Chou D; Niikura M; Tietjen I; Fedida D
    Mol Pharmacol; 2016 Aug; 90(2):80-95. PubMed ID: 27193582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent advances in computational studies on influenza a virus M2 proton channel.
    Wang JF; Chou KC
    Mini Rev Med Chem; 2012 Sep; 12(10):971-8. PubMed ID: 22420575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of Potent Antivirals against Amantadine-Resistant Influenza A Viruses by Targeting the M2-S31N Proton Channel.
    Li F; Ma C; Hu Y; Wang Y; Wang J
    ACS Infect Dis; 2016 Oct; 2(10):726-733. PubMed ID: 27657178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influenza virus M2 protein: a molecular modelling study of the ion channel.
    Sansom MS; Kerr ID
    Protein Eng; 1993 Jan; 6(1):65-74. PubMed ID: 7679490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protonation of histidine and histidine-tryptophan interaction in the activation of the M2 ion channel from influenza a virus.
    Okada A; Miura T; Takeuchi H
    Biochemistry; 2001 May; 40(20):6053-60. PubMed ID: 11352741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design and synthesis of pinanamine derivatives as anti-influenza A M2 ion channel inhibitors.
    Zhao X; Jie Y; Rosenberg MR; Wan J; Zeng S; Cui W; Xiao Y; Li Z; Tu Z; Casarotto MG; Hu W
    Antiviral Res; 2012 Nov; 96(2):91-9. PubMed ID: 22982118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Computational and experimental analysis of drug binding to the Influenza M2 channel.
    Alhadeff R; Assa D; Astrahan P; Krugliak M; Arkin IT
    Biochim Biophys Acta; 2014 Apr; 1838(4):1068-73. PubMed ID: 24016551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How to overcome resistance of influenza A viruses against adamantane derivatives.
    Scholtissek C; Quack G; Klenk HD; Webster RG
    Antiviral Res; 1998 Feb; 37(2):83-95. PubMed ID: 9588841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemical rescue of histidine selectivity filter mutants of the M2 ion channel of influenza A virus.
    Venkataraman P; Lamb RA; Pinto LH
    J Biol Chem; 2005 Jun; 280(22):21463-72. PubMed ID: 15784624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct measurement of the influenza A virus M2 protein ion channel activity in mammalian cells.
    Wang C; Lamb RA; Pinto LH
    Virology; 1994 Nov; 205(1):133-40. PubMed ID: 7526533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The L46P mutant confers a novel allosteric mechanism of resistance toward the influenza A virus M2 S31N proton channel blockers.
    Musharrafieh R; Lagarias PI; Ma C; Tan GS; Kolocouris A; Wang J
    Mol Pharmacol; 2019 Aug; 96(2):148-157. PubMed ID: 31175183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Steered molecular dynamics approach for promising drugs for influenza A virus targeting M2 channel proteins.
    Nguyen H; Le L
    Eur Biophys J; 2015 Sep; 44(6):447-55. PubMed ID: 26033540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Virtual Screening Identifies Chebulagic Acid as an Inhibitor of the M2(S31N) Viral Ion Channel and Influenza A Virus.
    Duncan MC; Onguéné PA; Kihara I; Nebangwa DN; Naidu ME; Williams DE; Balgi AD; Andrae-Marobela K; Roberge M; Andersen RJ; Niikura M; Ntie-Kang F; Tietjen I
    Molecules; 2020 Jun; 25(12):. PubMed ID: 32599753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The oligomeric state of the active BM2 ion channel protein of influenza B virus.
    Balannik V; Lamb RA; Pinto LH
    J Biol Chem; 2008 Feb; 283(8):4895-904. PubMed ID: 18073201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The ion channel activity of the influenza virus M2 protein affects transport through the Golgi apparatus.
    Sakaguchi T; Leser GP; Lamb RA
    J Cell Biol; 1996 May; 133(4):733-47. PubMed ID: 8666660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reconstitution of the influenza virus M2 ion channel in lipid bilayers.
    Tosteson MT; Pinto LH; Holsinger LJ; Lamb RA
    J Membr Biol; 1994 Oct; 142(1):117-26. PubMed ID: 7535851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potent inhibitor design against H1N1 swine influenza: structure-based and molecular dynamics analysis for M2 inhibitors from traditional Chinese medicine database.
    Lin CH; Chang TT; Sun MF; Chen HY; Tsai FJ; Chang KL; Fisher M; Chen CY
    J Biomol Struct Dyn; 2011 Feb; 28(4):471-82. PubMed ID: 21142218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. X-ray Crystal Structures of the Influenza M2 Proton Channel Drug-Resistant V27A Mutant Bound to a Spiro-Adamantyl Amine Inhibitor Reveal the Mechanism of Adamantane Resistance.
    Thomaston JL; Konstantinidi A; Liu L; Lambrinidis G; Tan J; Caffrey M; Wang J; Degrado WF; Kolocouris A
    Biochemistry; 2020 Feb; 59(4):627-634. PubMed ID: 31894969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.